125 related articles for article (PubMed ID: 582680)
1. Pharmacology of clovoxamine, a new non-tricyclic antidepressant.
Claassen V; Boschman TA; Dhasmana KM; Hillen FC; Vaatstra WJ; Zwagemakers JM
Arzneimittelforschung; 1978; 28(10):1756-66. PubMed ID: 582680
[No Abstract] [Full Text] [Related]
2. PS-2747: a new antidepressant agent.
Plotnikoff N; Will F; Evans A; Meekma P
Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):330-42. PubMed ID: 4622667
[No Abstract] [Full Text] [Related]
3. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
[TBL] [Abstract][Full Text] [Related]
4. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
Kitaichi Y
Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
[No Abstract] [Full Text] [Related]
5. Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
Pálosi E; Mészáros C; Szporny L
Arzneimittelforschung; 1969 Nov; 19(11):1882-7. PubMed ID: 5395660
[No Abstract] [Full Text] [Related]
6. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
Boksay IJ; Popendiker K; Weber RO; Söder A
Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
[TBL] [Abstract][Full Text] [Related]
7. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
Hoffmeister F
Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
[No Abstract] [Full Text] [Related]
8. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological properties of new antidepressive agent azaphen].
Mashkovskiĭ MD; Polezhaeva AI
Farmakol Toksikol; 1969; 32(6):656-62. PubMed ID: 5381594
[No Abstract] [Full Text] [Related]
10. 5-phenyl-2-furamidines: a new chemical class of potential antidepressants.
Pong SF; Pelosi SS; Wessels FL; Yu CN; Burns RH; White RE; Anthony DR; Ellis KO; Wright GC; White RL
Arzneimittelforschung; 1983; 33(10):1411-6. PubMed ID: 6140016
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacology of diphenylalkyl-derivatives. IV. Pharmacology of a noradrenaline increasing effect of dephenylpropylamine-amine-derivatives].
Leszkovszky GP; Tardos L; Lendvai J; Takács K
Arzneimittelforschung; 1967 Dec; 17(12):1590-5. PubMed ID: 5633110
[No Abstract] [Full Text] [Related]
12. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic basis for therapeutic interest in bupropion.
Soroko FE; Maxwell RA
J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and toxicological studies of binodaline hydrochloride.
Jahn U; Adrian RW; Ismail S; Michos N
Arzneimittelforschung; 1983; 33(5):726-39. PubMed ID: 6683551
[TBL] [Abstract][Full Text] [Related]
15. Phenacylthioimidazolines and 3-aryl-5,6-dihydroimidazo(2,1-b)thiazoles with antidepressant activity.
Sharpe CJ; Shadbolt RS; Ashford A; Ross JW
J Med Chem; 1971 Oct; 14(10):977-82. PubMed ID: 5165571
[No Abstract] [Full Text] [Related]
16. Pharmacological profile and mechanism of action of antidepressant drugs.
Maj J
Acta Physiol Pol; 1987; 38(4):289-301. PubMed ID: 2898869
[No Abstract] [Full Text] [Related]
17. Pharmacology of new tropine ethers with central activity.
György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
[No Abstract] [Full Text] [Related]
18. [Experimental study of pharmacological properties of nialamide].
Gilev AP; Terekhina AI; Tarasova EI; Khavronina ZP
Farmakol Toksikol; 1967; 30(3):328-31. PubMed ID: 4386187
[No Abstract] [Full Text] [Related]
19. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of McN-5707 as a potential antidepressant.
Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
